DISCO Pharmaceuticals
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $59M
Investors
- 6
About DISCO Pharmaceuticals
Based in Cologne, Germany, and co-founded by Roman Thomas (CEO) and Johannes Heuckmann (COO) in 2022, DISCO Pharmaceuticals GmbH operates as a pharmaceutical company offering a surfaceome mapping platform for viewing the entire cancer cell surface. The company specializes in cancer care by revolutionizing the discovery of molecular targets. DISCO's technology focuses on comprehensive mapping of the cancer cell surface, revealing new druggable targets beyond the scope of traditional proteomics or genomics. The company's mission is to enhance patient care through targeted cancer therapies, with initial projects concentrating on Small Cell Lung Cancer and microsatellite-stable Colorectal Cancer. The scalable drug discovery platform, agnostic to therapeutic modality and modular in application to cellular states, identifies proteins and protein communities, enabling the development of cancer-selective therapies.
Who invested in DISCO Pharmaceuticals
6 investors across 2 rounds
See all investors in DISCO Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DISCO Pharmaceuticals
Who invested in DISCO Pharmaceuticals?
DISCO Pharmaceuticals has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DISCO Pharmaceuticals raised?
DISCO Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did DISCO Pharmaceuticals last raise money?
DISCO Pharmaceuticals's most recent round on record is a Seed, in Feb 2025.
What does DISCO Pharmaceuticals do?
Based in Cologne, Germany, and co-founded by Roman Thomas (CEO) and Johannes Heuckmann (COO) in 2022, DISCO Pharmaceuticals GmbH operates as a pharmaceutical company offering a surfaceome mapping platform for viewing the entire cancer cell surface.
Where is DISCO Pharmaceuticals headquartered?
DISCO Pharmaceuticals is headquartered in Cologne, Germany.
Which VCs invest in companies like DISCO Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at DISCO Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like DISCO Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.